GENT, Belgium and MADISON, Wis., Sept. 8 /PRNewswire-FirstCall/ -- In U.S. District Court for the Western District of Wisconsin today, a jury unanimously found that Abbott Laboratories willfully infringed Innogenetics U.S. Patent No. 5,846,704 (“the ‘704 patent”), which covers a method of genotyping the Hepatitis C Virus (“HCV”).
